TREM2 and Alzheimer disease: Moreover, the results of a genome‐wide association study has implicated the triggering receptor expressed on myeloid cells 2 (TREM2) gene, which encodes a microglial cell surface protein, as the second most significant risk factor for late onset AD after APOE ε4 (Guerreiro et al., 2013).